Last updated on 12 Feb 2025
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2171301 filed on 21 Feb 2021
Correspondent
King & Spalding LLP, Maren C. Perry
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2171301
21 Feb 2021
NA
WORD
21 Aug 2020
US
Status Date | Action Taken |
---|---|
12th Feb 2025 | Status change to Voided |
29th Jun 2021 | International Registration in Australia Protected correspondence sent |
28th Jun 2021 | IP Right Registration Published |
28th Jun 2021 | Status change to Registered/Protected |
21st Apr 2021 | Application Accepted correspondence sent |
20th Apr 2021 | IP Right has been Examined |
20th Apr 2021 | IP Right Acceptance Published |
20th Apr 2021 | Status change to Accepted |
20th Apr 2021 | Examination expedited |
20th Apr 2021 | Awaiting examination |